Treatment for Stroke

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Emory Rehabilitation Hospital, Atlanta, GA
Stroke+2 More
Eligibility
18+
All Sexes
Eligible conditions
Select

Study Summary

Innovative Biofeedback Interface for Enhancing Stroke Gait Rehabilitation

See full description

Eligible Conditions

  • Stroke
  • Hemiplegic Gait

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether Treatment will improve 3 primary outcomes and 4 secondary outcomes in patients with Stroke. Measurement will happen over the course of Day 1, after each of the three biofeedback interface sessions.

Day 1
Game Ease of Use
Day 1
Change in Boredom
Change in Fatigue
Change in Hopkins Rehabilitation Engagement Rating Scale (HRERS) Score
Change in Motivation
Change in Pittsburgh Rehabilitation Participation Scale (PRPS) Score
Success rate of target paretic AGRF

Trial Safety

Safety Estimate

1 of 3

Trial Design

0 Treatment Group

This trial requires 12 total participants across 0 different treatment group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: day 1
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly day 1 for reporting.

Who is running the study

Principal Investigator
T. K.
Prof. Trisha Kesar, Assistant Professor
Emory University

Closest Location

Emory Rehabilitation Hospital - Atlanta, GA

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 4 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
chronic stroke (>6 months post stroke)
ambulatory with or without the use of a cane or walker
able to walk for 2 minutes at the self-selected speed without an orthoses
resting heart rate 40-100 beats per minute

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Stroke by sharing your contact details with the study coordinator.